Bellicum Pharmaceuticals, Inc. BLCM

Full chart Compare
Set alert

Price alert · BLCM

All alert types
0.07 0.00 (+0.00%)

Mar 4, 2024, 2:59 PM EST

0.0717 Day range 0.09

52-week range unavailable

Analyst view

Consensus: hold

Hold
Price target (mean) 5.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
  • Strong buy5
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 1
  • 2 months ago 1
  • 3 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BLCM analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.29-0.29 – -0.29-0.13-123.1%00.0%1
Next quarter-0.09-0.09 – -0.09-0.23+60.9%00.0%1
Current year-0.68-0.68 – -0.68-0.81+16.0%10.00K-99.3%1
Next year-0.96-0.96 – -0.96-0.68-41.2%00.0%1

Upgrades and downgrades

The latest rating changes

BLCM analyst upgrades and downgrades
DateFirmActionFromTo
Feb 16, 2022Ladenburg ThalmannInitiated—Buy
Nov 25, 2020Raymond JamesMaintained—Outperform
Nov 25, 2020CitigroupMaintainedBuyBuy
Nov 25, 2020Wells FargoUpgradeMarket PerformOutperform
Nov 25, 2020Wells FargoDowngradeOutperformMarket Perform
Nov 25, 2020Raymond JamesMaintained—Outperform
Nov 25, 2020Wells FargoInitiated—Outperform
Nov 25, 2020Raymond JamesInitiated—Outperform
Nov 25, 2020Ladenburg ThalmannInitiated—Buy
Nov 25, 2020Cantor FitzgeraldInitiated—Buy
Nov 25, 2020JefferiesMaintained—Buy
Nov 25, 2020CitigroupMaintained—Neutral
Nov 25, 2020CitigroupUpgradeNeutralBuy
Nov 25, 2020SunTrust Robinson HumphreyInitiated—Buy
Nov 25, 2020CitigroupInitiated—Neutral
Nov 25, 2020GuggenheimUpgrade—Buy
Nov 25, 2020CitigroupInitiated—Buy
Nov 25, 2020GuggenheimInitiated—Neutral
Nov 25, 2020CitigroupMaintained—Neutral
Nov 25, 2020PiperJaffrayInitiated—Overweight
Nov 25, 2020JefferiesInitiated——
Oct 30, 2020Wells FargoDowngradeOverweightEqual-Weight